Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silgan Holdings (SLGN) Payables (2016 - 2025)

Historic Payables for Silgan Holdings (SLGN) over the last 17 years, with Q3 2025 value amounting to $851.5 million.

  • Silgan Holdings' Payables rose 2549.75% to $851.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $851.5 million, marking a year-over-year increase of 2549.75%. This contributed to the annual value of $1.1 billion for FY2024, which is 331.76% up from last year.
  • Silgan Holdings' Payables amounted to $851.5 million in Q3 2025, which was up 2549.75% from $757.5 million recorded in Q2 2025.
  • Over the past 5 years, Silgan Holdings' Payables peaked at $1.1 billion during Q4 2021, and registered a low of $609.8 million during Q1 2024.
  • In the last 5 years, Silgan Holdings' Payables had a median value of $751.8 million in 2023 and averaged $802.4 million.
  • As far as peak fluctuations go, Silgan Holdings' Payables skyrocketed by 4121.62% in 2021, and later plummeted by 1576.01% in 2023.
  • Over the past 5 years, Silgan Holdings' Payables (Quarter) stood at $1.1 billion in 2021, then dropped by 14.06% to $974.0 million in 2022, then rose by 10.46% to $1.1 billion in 2023, then grew by 3.32% to $1.1 billion in 2024, then dropped by 23.4% to $851.5 million in 2025.
  • Its Payables was $851.5 million in Q3 2025, compared to $757.5 million in Q2 2025 and $736.8 million in Q1 2025.